Phreesia Yönetim
Yönetim kriter kontrolleri 2/4
Phreesia CEO'su Chaim Indig, Jan2005 tarihinde atandı, in görev süresi 19.83 yıldır. in toplam yıllık tazminatı $ 8.27M olup, şirket hissesi ve opsiyonları dahil olmak üzere 6% maaş ve 94% ikramiyelerden oluşmaktadır. şirketin hisselerinin 2.25% ine doğrudan sahiptir ve bu hisseler $ 24.06M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 17.1 yıldır.
Anahtar bilgiler
Chaim Indig
İcra Kurulu Başkanı
US$8.3m
Toplam tazminat
| CEO maaş yüzdesi | 6.0% |
| CEO görev süresi | 19.8yrs |
| CEO sahipliği | 2.2% |
| Yönetim ortalama görev süresi | 3.8yrs |
| Yönetim Kurulu ortalama görev süresi | 17.1yrs |
Son yönetim güncellemeleri
Recent updates
Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues
Nov 07
Is Phreesia (NYSE:PHR) Weighed On By Its Debt Load?
Oct 08Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results
Sep 06Phreesia: Remain Bullish Given The Healthy Growth Outlook
Sep 05Market Participants Recognise Phreesia, Inc.'s (NYSE:PHR) Revenues Pushing Shares 26% Higher
Jul 18Phreesia: Growth Remains Strong, With EBITDA Margin Set To Improve
Jun 06The Price Is Right For Phreesia, Inc. (NYSE:PHR)
May 25Are Investors Undervaluing Phreesia, Inc. (NYSE:PHR) By 39%?
May 03At US$23.80, Is Phreesia, Inc. (NYSE:PHR) Worth Looking At Closely?
Apr 12Phreesia Continues To Stay Positive On The Business Growth
Apr 03Phreesia: Healthcare Digitization Beneficiary Hampered By Valuation
Mar 01Investors Still Waiting For A Pull Back In Phreesia, Inc. (NYSE:PHR)
Feb 16Phreesia: Remain Buy Rated As The Business Pivot Towards Profitable Growth
Jan 04Is Phreesia Finally Turning The Corner?
Dec 07Does Phreesia (NYSE:PHR) Have A Healthy Balance Sheet?
Oct 25Phreesia: Share Price Dip Is A Buying Opportunity
Sep 21Phreesia: Strong Execution Should Continue To Drive Growth
Jul 11Phreesia, Inc.'s (NYSE:PHR) Share Price Matching Investor Opinion
May 18Phreesia: Strong Growth Momentum With Expanded TAM
Jan 28Phreesia - Healthcare Ecosystem At An Attractive Valuation
Dec 13Phreesia Q3 2023 Earnings Preview
Dec 07Phreesia GAAP EPS of -$0.89 beats by $0.08, revenue of $67.9M beats by $2.15M
Sep 07Phreesia: Their Time Has Passed
May 10Opportunistic Time To Buy Phreesia's Healthcare Disruption
Dec 27CEO Tazminat Analizi
| Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
|---|---|---|---|
| Jul 31 2024 | n/a | n/a | -US$100m |
| Apr 30 2024 | n/a | n/a | -US$119m |
| Jan 31 2024 | US$8m | US$495k | -US$137m |
| Oct 31 2023 | n/a | n/a | -US$144m |
| Jul 31 2023 | n/a | n/a | -US$152m |
| Apr 30 2023 | n/a | n/a | -US$162m |
| Jan 31 2023 | US$8m | US$515k | -US$176m |
| Oct 31 2022 | n/a | n/a | -US$185m |
| Jul 31 2022 | n/a | n/a | -US$181m |
| Apr 30 2022 | n/a | n/a | -US$158m |
| Jan 31 2022 | US$9m | US$515k | -US$118m |
| Oct 31 2021 | n/a | n/a | -US$80m |
| Jul 31 2021 | n/a | n/a | -US$50m |
| Apr 30 2021 | n/a | n/a | -US$32m |
| Jan 31 2021 | US$6m | US$419k | -US$27m |
| Oct 31 2020 | n/a | n/a | -US$23m |
| Jul 31 2020 | n/a | n/a | -US$19m |
| Apr 30 2020 | n/a | n/a | -US$83m |
| Jan 31 2020 | US$10m | US$346k | -US$91m |
| Oct 31 2019 | n/a | n/a | -US$102m |
| Jul 31 2019 | n/a | n/a | -US$113m |
| Apr 30 2019 | n/a | n/a | -US$54m |
| Jan 31 2019 | US$510k | US$300k | -US$45m |
Tazminat ve Piyasa: Chaim 'nin toplam tazminatı ($USD 8.27M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 3.21M ).
Tazminat ve Kazançlar: Chaim şirketinin tazminatı, şirket kârsız olduğu sürece artırıldı.
CEO
Chaim Indig (44 yo)
19.8yrs
Görev süresi
US$8,273,307
Tazminat
Mr. Chaim Indig co-founded Phreesia, Inc. in January 2005 and serves as Chief Executive Officer and Director since January 2005. Mr. Indig has helped to revolutionize the patient check-in experience. Under...
Liderlik Ekibi
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 19.8yrs | US$8.27m | 2.25% $ 24.1m | |
| Co-Founder & COO | 19.8yrs | US$4.50m | 1.3% $ 14.0m | |
| Chief Financial Officer | 1.7yrs | US$5.91m | 0.17% $ 1.8m | |
| General Counsel & Secretary | 4.3yrs | US$3.04m | 0.082% $ 877.5k | |
| Senior Vice President of Life Sciences | 5.7yrs | US$4.47m | 0.36% $ 3.9m | |
| VP & Principal Accounting Officer | less than a year | Veri yok | Veri yok | |
| Chief Technology Officer | less than a year | Veri yok | Veri yok | |
| Vice President of Corporate Communications | 3.8yrs | Veri yok | Veri yok | |
| Vice President of Sales & Marketing Operations | no data | Veri yok | Veri yok | |
| Senior Vice President of Human Resources | 14.6yrs | Veri yok | 0.21% $ 2.2m | |
| Chief Clinical Officer | 3.6yrs | Veri yok | Veri yok | |
| Chief Privacy Officer | 1.4yrs | Veri yok | Veri yok |
3.8yrs
Ortalama Görev Süresi
44yo
Ortalama Yaş
Deneyimli Yönetim: PHR 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).
Yönetim Kurulu Üyeleri
| İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
|---|---|---|---|---|
| Co-Founder | 19.8yrs | US$8.27m | 2.25% $ 24.1m | |
| Board Observer | no data | Veri yok | Veri yok | |
| Independent Director | 17.1yrs | US$232.46k | 0.065% $ 696.3k | |
| Independent Chairman | 19.8yrs | US$384.98k | 0.57% $ 6.2m | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Independent Director | 5.5yrs | US$257.46k | 0.018% $ 189.2k | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Member of Medical Advisory Board | no data | Veri yok | Veri yok | |
| Independent Director | 6.1yrs | US$244.98k | 0.011% $ 113.2k |
17.1yrs
Ortalama Görev Süresi
62yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: PHR 'in yönetim kurulu deneyimli ve tecrübelidir (ortalama görev süresi 17.1 yıldır).